Home » Stocks » ARPO

Aerpio Pharmaceuticals, Inc. (ARPO)

Stock Price: $2.12 USD -0.04 (-1.85%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $2.16 +0.04 (1.89%) Jul 29, 7:58 PM
Market Cap 97.58M
Revenue (ttm) 15.00M
Net Income (ttm) -4.84M
Shares Out 47.28M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $2.12
Previous Close $2.16
Change ($) -0.04
Change (%) -1.85%
Day's Open 2.18
Day's Range 2.10 - 2.28
Day's Volume 830,750
52-Week Range 0.95 - 3.32

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Looking For the Best Penny Stocks to Watch in July? Check These 4 Out The post Penny Stocks to Buy Right Now?

Other stocks mentioned: CFMS, DPW, INVU
1 week ago - PennyStocks

Reopening penny stocks are showing momentum right now; here's 6 to watch The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News...

Other stocks mentioned: ABEV, ADXS, AHT, GSAT, SONM
1 week ago - PennyStocks

Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other stocks mentioned: ACST, APOP, CHEK, SEEL, WORX
2 weeks ago - PennyStocks

NEW YORK , July 10, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM)  concerning pot...

Other stocks mentioned: CHMA, NETE, ONEM, SOLY, SYKE
2 weeks ago - PRNewsWire

Shares of microcap biopharma Aerpio Pharmaceuticals, Inc. (ARPO) are advancing strongly Thursday on above-average volume. The upside in reaction a positive analyst action.

3 weeks ago - Benzinga

Digital Brands (DBGI) stock is rocketing higher on Thursday after revealing estimated financial data for its upcoming quarter. The post DBGI Stock: 13 Things to Know About Digital Brands as Shares Take ...

Other stocks mentioned: CARV, DBGI
3 weeks ago - InvestorPlace

Aerpio Pharmaceuticals (ARPO) stock is flying high on Thursday after an analyst upgrade gave the company's shares a boost today. The post ARPO Stock: 12 Things to Know About Aerpio Pharma as Analyst Upg...

Other stocks mentioned: CARV
3 weeks ago - InvestorPlace

Why investors are watching these 7 penny stocks right now The post Which Penny Stocks Are Investors Buying Right Now? 7 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informat...

Other stocks mentioned: ABUS, CRBP, DBGI, JFU, NBY, NXE
3 weeks ago - PennyStocks

CINCINNATI, June 04, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) announced that Aadi Bioscience, Inc. (“Aadi”), a privately-held biopharmaceutical company focusing on...

1 month ago - GlobeNewsWire

NEW YORK, May 21, 2021 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action...

2 months ago - PRNewsWire

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Aerpio Pharmaceu...

2 months ago - Business Wire

CINCINNATI, May 19, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) announced that Aadi Bioscience (“Aadi”), a privately-held biopharmaceutical company focusing on precis...

2 months ago - GlobeNewsWire

NEW YORK, May 19, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerpio Pharmaceuticals, Inc. ("Aerpio" o...

2 months ago - PRNewsWire

Looking for 7 penny stocks that could be buy the dip candidates? Check these out The post 7 Penny Stocks to Watch With Crypto News Sparking a Market Dip appeared first on Penny Stocks to Buy, Picks, New...

Other stocks mentioned: ATOS, GSAT, IDEX, NWBO, PLIN, SENS
2 months ago - PennyStocks

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) and Aadi Bioscience, Inc. is fair to Ae...

2 months ago - Business Wire

Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) has agreed to merge with a privately-held Aadi Bioscience. Following the proposed merger, the new entity will operate under the Aadi Bioscience moniker and focu...

2 months ago - Benzinga

These penny stocks moved big in early morning trading; here's why The post Penny Stocks to Buy in May 2021? Here's 3 Big Pre-Market Gainers appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other stocks mentioned: IDEX, ONTX
2 months ago - PennyStocks

CINCINNATI, May 17, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2, today reported financ...

2 months ago - GlobeNewsWire

CINCINNATI and PACIFIC PALISADES, Calif., May 17, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activa...

2 months ago - GlobeNewsWire

Aerpio Pharmaceuticals (ARPO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

3 months ago - Zacks Investment Research

Aerpio Pharmaceuticals, Inc. (ARPO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

4 months ago - Zacks Investment Research

CINCINNATI, March 11, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio” or the “Company”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 in ...

4 months ago - GlobeNewsWire

Quantum Leap Healthcare Collaborative-sponsored I-SPY COVID Trial will not further test Aerpio Pharmaceuticals Inc's (NASDAQ: ARPO) razuprotafib. Razuprotafib was chosen because it was believed to stabi...

4 months ago - Benzinga

SAN FRANCISCO and CINCINNATI, March 05, 2021 (GLOBE NEWSWIRE) -- Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with further testing of the Aerpio P...

4 months ago - GlobeNewsWire

Aerpio (ARPO) will provide updates on its pipelinewhen it reports fourth-quarter 2020 results.

5 months ago - Zacks Investment Research

Aerpio (ARPO) unveils strategic alternatives after it announced top-line results from a phase II study of razuprotafib in glaucoma patients in December.

6 months ago - Zacks Investment Research

Aerpio Pharmaceuticals (ARPO) has been struggling lately, but the selling pressure may be coming to an end soon.

6 months ago - Zacks Investment Research

CINCINNATI, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio” or the “Company”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2, tod...

6 months ago - GlobeNewsWire

Does Aerpio Pharmaceuticals, Inc. (ARPO) have what it takes to be a top stock pick for momentum investors? Let's find out.

7 months ago - Zacks Investment Research

Even as the broader market trades higher in reaction to the availability of the first coronavirus vaccine under emergency use authorization, a slew of biopharma stocks are moving on company-specific upd...

Other stocks mentioned: ANPC, ARVN, SYBX, VERU
7 months ago - Benzinga

Primary endpoint achieved with twice-daily dose group at 28 day time point versus latanoprost control group.

7 months ago - GlobeNewsWire

Here we discuss three potential stocks that can gain following mass availability of vaccine. Vaccination may release pent-up demand across sectors.

Other stocks mentioned: RGEN, TCON
7 months ago - Zacks Investment Research

Aerpio Pharmaceuticals, Inc. (ARPO) Management on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Conference Call Today, November 10 , 2020 at 8:30 a.m. EST

8 months ago - GlobeNewsWire

CINCINNATI, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular disea...

8 months ago - GlobeNewsWire

Call Taking Place on Thursday, November 12th @ 11amET Call Taking Place on Thursday, November 12th @ 11amET

8 months ago - GlobeNewsWire

The trial in moderate-to-severe patients is Aerpio's second clinical trial in COVID-19 patients and is funded in part by the U . S . military

9 months ago - GlobeNewsWire

Topline Data Expected 4Q 2020 Topline Data Expected 4Q 2020

10 months ago - GlobeNewsWire

SAN FRANCISCO and CINCINNATI, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. ("Aerpio") (Nasdaq: ARPO) and Quantum Leap Healthcare Collaborative™ (Quantum Leap) announced today dosing...

10 months ago - GlobeNewsWire

Aerpio Pharmaceuticals' (ARPO) Management on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Conference Call Today, August 12, 2020 at 8:30 a.m. EDT

11 months ago - GlobeNewsWire

CINCINNATI, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular dis...

11 months ago - GlobeNewsWire

CINCINNATI, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) and The U.S. Government operating through the Medical Technology Enterprise Consortium (MTEC) annou...

11 months ago - GlobeNewsWire

In the latest trading session, Aerpio Pharmaceuticals, Inc. (ARPO) closed at $1.26, marking a +1.61% move from the previous day.

1 year ago - Zacks Investment Research

Is (ARPO) Outperforming Other Medical Stocks This Year?

1 year ago - Zacks Investment Research

As of late, it has definitely been a great time to be an investor in Aerpio Pharmaceuticals.

1 year ago - Zacks Investment Research

Aerpio Pharmaceuticals, Inc. (ARPO) closed the most recent trading day at $1.25, moving +0.81% from the previous trading session.

1 year ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for June 19th

Other stocks mentioned: DLTH
1 year ago - Zacks Investment Research

Is (ARPO) Outperforming Other Medical Stocks This Year?

1 year ago - Zacks Investment Research

CINCINNATI, June 08, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (the “Company”) (Nasdaq: ARPO), today announced that, due to the public health and safety concerns related to the novel coron...

1 year ago - GlobeNewsWire

About ARPO

Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing compounds that activate Tie2 for the treatment of ocular disease and vascular stabilization. The company's lead product candidate is razuprotafib, a small molecule inhibitor of vascular endothelial protein tyrosine phosphatase , which has completed phase IIb clinical trial for the treatment of non-proliferative diabetic retinopathy, as well as has completed phase II clinical trial for the treatment of patients with open angle glaucoma/ocular hyp... [Read more...]

Industry
Biotechnology
Stock Exchange
NASDAQ
Ticker Symbol
ARPO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for ARPO stock is "Buy." The 12-month stock price forecast is 22.00, which is an increase of 937.74% from the latest price.

Price Target
$22.00
(937.74% upside)
Analyst Consensus: Buy